Trilogy Capital Inc. has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The report lists 427 distinct positions held by the firm, which is headquartered at 2601 Main St Suite 100 in Irvine, California.
The filing identifies June Adams as the Chief Compliance Officer responsible for the report, which was submitted on October 20, 2026. The document provides a detailed list of the common stock and exchange-traded fund positions held by the firm during the specified reporting period.
The portfolio includes a mix of large-cap technology companies, such as Apple Inc., Amazon.com Inc., and Alphabet Inc. Class A and C shares. The filing also lists significant positions in healthcare companies like Eli Lilly & Co. and Gilead Sciences Inc., as well as energy companies including Chevron Corporation and ExxonMobil Holdings Corp.
In addition to individual equities, the report includes a substantial number of exchange-traded funds (ETFs). Holdings include the Invesco QQQ Trust Unit Series 1, iShares Core S&P 500 ETF, and various bond and sector-specific ETFs managed by firms like iShares, Invesco, and First Trust.
The filing also notes several options positions, including call options on Applied Optoelectronics Inc. and Astera Labs Inc., as well as put options on Crocs Inc. and ExxonMobil Holdings Corp.
